Should You Accumulate Assembly Biosciences Inc (ASMB) Stock Monday Morning?

Assembly Biosciences Inc (ASMB) is lower by Monday morning, with the stock losing -2.98% in pre-market trading to 1.63. ASMB's short-term technical score of 49 indicates that the stock has traded less bullishly over the last month than 51% of stocks on the market. In the Biotechnology industry, which ranks 120 out of 146 industries, the stock ranks higher than 60% of stocks. Assembly Biosciences Inc has risen 21.74% over the past month, closing at $1.59 on January 9. During this period of time, the stock fell as low as $1.49 and as high as $1.78. ASMB has an average analyst recommendation of Buy. The company has an average price target of $2.38.

ASMB has an Overall Score of 45. Find out what this means to you and get the rest of the rankings on ASMB!

See Full ASMB Report

Assembly Biosciences Inc has a Long-Term Technical rank of 32. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 68% of the market scoring higher. In the Biotechnology industry which is number 128 by this metric, ASMB ranks better than 128% of stocks.

Important Dates for Investors in ASMB:

-Assembly Biosciences Inc is set to release earnings on 3/9/2023. Over the last 12 months, the company has reported EPS of $-2.84. -We do not have a set dividend date for Assembly Biosciences Inc at this time. Click Here To Get The Full Report on Assembly Biosciences Inc (ASMB)